Biodelivery Sciences International Inc (BDSI) Growth Rates Comparisons to Major Pharmaceutical Preparations Industry, Sector, Market. Sales, Income, EPS
CSIMarket Company Name, Ticker, Customers, else..
 
Biodelivery Sciences International Inc   (NASDAQ: BDSI)
 

Biodelivery Sciences International Inc Growth Comparisons

Select each growth Category to receive further Information




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BDSI Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q4 MRQ) 2.33 % 16.1 % 13.4 % 15.06 %
Q / Q Revenue Growth (Q4 MRQ) 5.01 % 4.88 % 4.48 % 4.87 %
Y / Y Revenue Growth (for 12 months ending Q4 TTM) 6.54 % 22.84 % 19.76 % %
Sequential Revenue Growth (for 12 months ending Q4 TTM) 0.59 % 8.4 % 5.47 % 3.47 %
Revenue 5 Year Average Growth 60.72 % 17.92 % 12.9 % 12.72 %


BDSI's Growth Comparisons in IV. Quarter 2021




Biodelivery Sciences International Inc 's Revenue slowed to the 2.33% year on year, improvement in the fourth quarter 2021 to 43 millions, underperforming the 16.1% rise in the Major Pharmaceutical Preparations industry and 13.4% Revenue improvement in the Healthcare sector. Comparing the fourth quarter, sales Biodelivery Sciences International Inc was trailing overall market not just Major Pharmaceutical Preparations industry.

Comparing the company's Revenue to the third quarter results, sales were higher by 5.01% . On the yearly basis, average annual sales growth for Biodelivery Sciences International Inc is 60.72%, while S & P 500's including only Businesses with the fourth quarter 2021 earnings, average annual sales growth is 12.72% over the past five years.


Growth Rates of BDSI's Income in the fourth quarter 2021


BDSI Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q4 MRQ) -27.33 % - 125.24 % 73.49 %
Sequential Operating Income Change (Q4 MRQ) -2.25 % -24.98 % 14.98 % 6.63 %
Y / Y Operating Income Growth (Q4 TTM) 12.57 % 93.82 % 68.67 % 62.11 %
Sequential Operating Income Growth (Q4 TTM) -8.4 % 38.93 % 23.85 % 10.12 %
Operating Income 5 Year Avg. Change - 22.63 % 11.58 % 16.54 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q4 MRQ) 526.56 % - 201.24 % 64.35 %
Sequential Income from Cont. Ops. Change (Q4 MRQ) 858.01 % -19.96 % -24.11 % -3.45 %
Y / Y Income from Cont. Ops. Change (Q4 TTM) 230.05 % 177.49 % 111.3 % 73.06 %
Sequential Income from Cont. Ops. Change (Q4 TTM) 172.28 % 71.44 % 36.64 % 7.01 %
Income from Cont. Ops. 5 Year Avg. Change - 41.22 % 20.87 % 23.18 %

BDSI Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q4 MRQ) 526.56 % - 2107.77 % 67.32 %
Q / Q Net Income Growth (Q4 MRQ) 858.01 % -17.44 % -28.59 % -3.75 %
Y / Y Net Income Change (Q4 TTM) 230.05 % 183.76 % 131.76 % 74.74 %
Sequential Net Income Change (Q4 TTM) 172.28 % 76.68 % 43.04 % 7.63 %
Net Income 5 Year Avg. Growth - 40.18 % 20.57 % 22.5 %

BDSI's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q4 MRQ) 540 % - 201.24 % 64.35 %
Sequential EPS from Cont. Ops. Change (Q4 MRQ) 814.29 % -20.68 % -24.11 % -3.45 %
Y / Y EPS from Cont. Ops. Change (Q4 TTM) 240 % - - -
Sequential EPS from Cont. Ops. Change (Q4 TTM) 174.19 % 0.06 % - -99.02 %
EPS from Cont. Ops. 5 Year Avg. Growth - 25.95 % 20.87 % 23.18 %



BDSI EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q4 MRQ) 521.28 % - 2107.77 % 23.18 %
Q / Q EPS Net Growth (Q4 MRQ) 787.55 % -18.19 % -28.59 % -3.75 %
Y / Y EPS Net Change (for 12 months ending Q4 TTM) - 5683.45 % - 24461.96 %
Sequential EPS Net Change (for 12 months ending Q4 TTM) 168.16 % 783.57 % - 0.2 %
EPS Net 5 Year Avg. Change - 40.18 % 20.57 % 22.5 %



Reporting 521.28% surge year on year in the fourth quarterEPS, Biodelivery Sciences International Inc led the 16.1% rise in the Major Pharmaceutical Preparations industry, but Biodelivery Sciences International Inc 's growth compares unfavorably, to the 2107.77% EPS surge in the Healthcare sector.

The Company's sequential EPS growth rate was very impressive 787.55% from the third quarter. Average yearly income per share growth for Biodelivery Sciences International Inc is 60.72%, while S & P 500's average annual income per share growth is 22.5% over the five years, including only Businesses with the fourth quarter 2021 earnings results.

BDSI Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q4 MRQ) 24.95 % -13.78 % -3.72 % 11.77 %
Sequential Free Cash Flow Change (Q4 MRQ) 97.47 % -42.02 % -23.17 % -1.69 %
Y / Y Free Cash Flow Change (Q4 TTM) 62.7 % 45.46 % 22.45 % -7.9 %
Sequential Free Cash Flow Change (Q4 TTM) 7.25 % 8.26 % 1.68 % 0.92 %
Free Cash Flow 5 Year Avg. Change - 27.93 % 18.33 % 35.41 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q4 MRQ) 19.22 % - - -72.21 %
Sequential Net Cash Flow Change (Q4 MRQ) - - - -50.53 %
Y / Y Net Cash Flow Change (Q4 TTM) -94.29 % 160.26 % 0.45 % -73.04 %
Sequential Net Cash Flow Change (Q4 TTM) - 8.2 % 23.14 % -28.17 %
Net Cash Flow 5 Year Avg. Change - 54.4 % 87.74 % 114.8 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q4 MRQ) - -10.85 % 17.14 % 2.27 %
Sequential Capital Expenditures Change (Q4 MRQ) - 23.05 % 35 % 32.73 %
Y / Y Capital Expenditures Change (Q4 TTM) 3092.31 % 1.6 % 10.76 % -20.85 %
Sequential Capital Expenditures Change (Q4 TTM) -3.04 % 0.03 % 2.68 % 6.1 %
Capital Expenditures 5 Year Avg. Change - 15.7 % 11.36 % 12.23 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.